Desk Report
Publish: 22 Sep 2021, 09:49 pm
AstraZeneca Covishield || Photo; Collected
Covishield
is now an approved vaccine on the UK's revised guidelines for travel after a
furious India warned of "reciprocal measures", but double-vaccinated
Indians still have to quarantine because of "vaccination certification
issues", according to UK officials.
Officials
have implied the problem is not Covishield but doubts over vaccine
certification in India.
Responding
to the new sticking point, a top health official told NDTV there are "no
issues" with the Indian vaccine certificate.
The
updated UK travel guidelines say, "Formulations of the four listed
vaccines, such as AstraZeneca Covishield, AstraZeneca Vaxzevria and Modern
Takeda, qualify as approved vaccines." The site explains that from 4 am,
October 4, those who have taken vaccines from a "relevant public health
body" in specific countries will be considered "fully vaccinated".
That list does not include India.
This
suggests that Indians vaccinated with two doses of Covishield, produced by
Serum Institute of India (SII), will still need to quarantine even though India
is now on the Amber list.
Speaking
to NDTV, British High Commissioner to India Alex Ellis said, "India is
still on the Amber category because there are still some COVID-19 cases in
India. Most other nations on the list that do not need any quarantine are in
the green category, where the number of active cases are very low in
comparison."
"While
Covishield is approved, the UK government is still trying to understand how the
Indian Covid vaccine app works. And let me assure you, that this is a two-way
process. We are also letting India know how the UK government Covid app works.
Once we understand this better and know that it is absolutely safe, we can go
ahead and remove the quarantine for Indian travellers," he said.
A
British High Commission statement yesterday said: "We are engaging with
the Government of India to explore how we could expand UK recognition of
vaccine certification to people vaccinated by a relevant public health body in
India."
Certification
after Covid jabs in India is a centralised national system managed through the
CoWin app and portal.
RS
Sharma, the CEO of the National Health Authority, told NDTV there are "no
issues" on CoWin with Covid certification.
"The
system is entirely WHO (World Health Organisation) compliant. We continue to
have discussions with the International Civil Aviation Organisation as well.
The UK High Commissioner visited me on September 2. They wanted to understand
the CoWin system, the technical aspects. A resource has been allocated to them
for this purpose and two further conversations have happened with their team.
These were technical-level conversations," Dr Sharma said.
Serum
Institute's Adar Poonawalla, expressing "delight" at Covishield being
recognised, noted that the matter for Indians travelling to the UK was still
not resolved.
"We
are delighted that Covishield is recognised as a vaccine equivalent to
AstraZeneca on the official gov.uk website. However, the matter for travel and
quarantine is not resolved and all those looking to travel to the UK should
carefully follow official entry guidelines,'' Mr Poonawalla told NDTV.
India
had warned of "reciprocal measures" if Covishield, the Indian version
of the Oxford AstraZeneca vaccine, was not recognized.
"The non-recognition of Covishield is a discriminatory policy and impacts our citizens travelling to the UK. The External Affairs Minister has raised the issue strongly with the new UK foreign secretary. I am told that certain assurances have been given that this issue will be resolved," Foreign Secretary Harsh Vardhan Shringla had told reporters yesterday. (NDTV)
Subscribe Shampratik Deshkal Youtube Channel
Topic : Covishield UK
© 2024 Shampratik Deshkal All Rights Reserved. Design & Developed By Root Soft Bangladesh